MPT
Medical Properties Trust, Inc.
$2.74
-3.86% 2026-10-20
Real EstateS&P 600
MPTSPY
1W
-12.5%
1M
-19.4%
3M
-42.4%
6M
-45.0%
YTD
-41.8%
1Y
-43.3%
Live chart
Loading live chart…
Grades vs sector
Momentum6th pct in sectorF
Momentum
6th pct in sector
12-1 return: -27.7%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Growth22nd pct in sectorD
Growth
22nd pct in sector
Revenue growth (YoY): +1.9%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Value57th pct in sectorB-
Value
57th pct in sector
Forward E/P: 1.7% · EBITDA/EV: 8.5%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Profitability13th pct in sectorD-
Profitability
13th pct in sector
Profit margin: -2.7% · Return on equity: -0.6%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Quality Growth
not ranked (outside this model's universe or screens)
Momentum Top 15not ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More newsMedical Properties Trust (MPT) Stock May Be Below Fair Value On Cash Flow
Simply Wall St. · Oct 17
MPT Named to Modern Healthcare’s Best Places to Work 2026 and Newsweek’s America’s Greenest Companies 2027
Business Wire · Oct 13
6 High-Yield Stocks Where the Market May Be Warning of a Dividend Cut
24/7 Wall St. · Oct 01
Is Medical Properties Trust (MPT) Finally Fixing Its Balance Sheet?
Insider Monkey · Sep 23
Medical Properties Trust (MPT) Receives $371M. Will Debt Reduction Outweigh Lost Rent?
Insider Monkey · Sep 20
Key stats
Market cap$1.6B
P/E (trailing)–
P/E (forward)54.8
52-week range2.73 – 6.47
Revenue growth (YoY, latest qtr)+1.9%
Dividend yield12.63%
Analyst consensusNone (6)
Mean price target$5.12 (+87%)
Valuation and fundamentals
Valuation & fundamentals
Bottom line
Looks expensive
Model read-out from the numbers below, not advice. Score -4 (DCF counts double).
▼DCF (base case)below the price by 566%
▼Forward P/E vs sector54.8x vs median 29.6x
•Piotroski F-score4/9
▼Altman Z-0.1 (distress)
▼Net debt / EBITDA12.1x
▲Analyst target+87% (6 analysts)
Discounted cash flow
Bear
$-14
-596%
growth -10% · disc. 12.7% · term. 2.0%
Base
$-13
-566%
growth -5% · disc. 11.7% · term. 2.5%
Bull
$-12
-531%
growth -2% · disc. 10.7% · term. 3.0%
A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price assumes free cash flow grows about 24% a year for 10 years.
Implied
+24%/yr
FCF, last 3 yrs
-32%/yr
FCF, last 5 yrs
-18%/yr
Revenue, last 3 yrs
-14%/yr
Revenue, last 5 yrs
-5%/yr
Same inputs as the DCF above: trailing free cash flow 0.2B, 11.7% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-03-31). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.49 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs Real Estate
P/E (trailing)
sector median 27.6×
–Forward P/E
pricier
sector median 29.6× · 80th pct
54.8×pricier
EV / EBITDA
cheaper
sector median 17.2× · 20th pct
14.2×cheaper
Price / sales
cheaper
sector median 6.5× · 7th pct
1.6×cheaper
Price / book
cheaper
sector median 1.8× · 1st pct
0.4×cheaper
FCF yield
cheaper
sector median 6.9% · 90th pct
13.2%cheaper
Forward EPS $0.05 vs trailing $-0.05. Forward P/E uses analysts' next-12-month estimate.
Quality & financial health
Gross margin
89.4%
Operating margin
48.5%
FCF margin
21.6%
Net margin
-12.6%
Return on equity
-2.8%
Return on invested capital
2.8%
Net debt / EBITDA
12.1×
Current ratio
–
Interest cover
0.9×
Cash conversion (OCF/NI)
–
Piotroski F-score 4/9 · last two fiscal years
✗ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✗ Gross margin improved✗ Asset turnover improved
Altman Z-score -0.1 (distress zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$5
+87%
Analysts
6
None
Range
$4–$7
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $972.0M | $-277.0M | $230.8M |
| 2024 | $995.5M | $-2.4B | $245.5M |
| 2023 | $871.8M | $-556.5M | $505.8M |
| 2022 | $1.5B | $902.6M | $739.0M |
| 2021 | $1.5B | $656.0M | $811.7M |
| 2020 | $1.2B | $431.4M | $617.6M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR -14.3%.
Earnings
Next report: 2026-10-29 · before open
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-10 | – | 0.01 | – |
| 2026-04-30 | 0.01 | 0.09 | +1662.0% |
| 2026-02-19 | – | 0.07 | – |
| 2025-10-30 | 0.02 | -0.13 | -641.7% |
| 2025-07-31 | 0.02 | -0.16 | -1076.8% |
| 2025-05-01 | -0.01 | -0.20 | -2467.4% |
| 2025-02-27 | -0.06 | -0.69 | -1145.9% |
| 2024-11-07 | 0.10 | -0.09 | -192.7% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $259.3M | +7.9% |
| 2026-03-31 | $252.1M | – |
| 2025-12-31 | $270.3M | – |
| 2025-09-30 | $237.5M | – |
| 2025-06-30 | $240.4M | – |
Analyst actions
Wells Fargo
PT $4
2026-09-01 · main
Underweight → UnderweightPT $4
RBC Capital
PT $4
2026-06-18 · main
Sector Perform → Sector PerformPT $4
RBC Capital
PT $5
2026-03-02 · main
Sector Perform → Sector PerformPT $5
Wells Fargo
PT $5
2025-11-25 · main
Underweight → UnderweightPT $5
Wells Fargo
PT $4
2025-08-27 · main
Underweight → UnderweightPT $4
Recent dividends
2026-09-10: $0.090 · 2026-06-18: $0.090 · 2026-03-12: $0.090 · 2025-12-11: $0.090 · 2025-09-11: $0.080 · 2025-06-18: $0.080 · 2025-03-10: $0.080 · 2024-12-12: $0.080
Insider trades
Hanna James Kevin
$9.5K
Senior VP, Controller & CAO · 2026-08-20
BUY$9.5K
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
Stats refreshed 2026-10-20 17:52:23 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteauCoteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.